Loading…
← CockpitCompetitor Analysis › INDRAMEDCO.NS Indraprastha Medical Corporation LimitedOpen in the cockpit ↗

Indraprastha Medical Corporation LimitedINDRAMEDCO.NSCompetitor analysis, valuation and peers

India · INR·Pharma & Healthcare›Hospital/Nursing Management
Momentum strong 61
Mkt cap
$351M
US dollars, full cap
Free float
45%
of shares outstanding
$/day
$1.53M
20-day average traded
Fwd P/E
15.9×
forward earnings
ROIC−WACC
+19.5 pp
WACC 15.2%
Hurdle
-4 pp
Req g minus delivered
Next earnings
83 days
9 Feb 2027
Close · INR₹358.00
1D+1.4%
1W+5.8%
1M+13.5%
3M-3.0%
6M-0.4%
YTD-20.1%
1Y-34.6%
ATR %3.4%
Beta1.16
52w lowhigh35.4% off high

What Indraprastha Medical does

Employees: 3,000

Indraprastha Medical at a glance

Size Indraprastha Medical (INDRAMEDCO.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $351M, the 1002nd largest of 1,066 India companies the cockpit tracks. Shares closed at ₹358.00 on 18 Nov 2026.

Performance Over six months the shares fell 0.4%, against -5.6% for the median peer and +3.8% for the India market (cap-weighted) — 8th highest of 19 in its peer set.

Growth Revenue grew 10.7% over the last twelve months (peer median +11.9%); the operating margin is 15.0% (peer median 10.2%).

Valuation It trades at 15.9× forward earnings against a peer median of 22.5× (4th cheapest of 14).

Price implies For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is +19%, so the hurdle is -4 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 19.5 points above its cost of capital (15.2% WACC).

Next results Next results expected around 9 Feb 2027 (exchange calendar; dates can move).

Relative performance

9010011021 May 202621 Aug 202618 Nov 2026INDRAMEDCO.NS 99Peer median 93
Six months, rebased to 100: Indraprastha Medical against the median of its 20 peers (local-currency closes).

Indraprastha Medical financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹15.6B₹14.8B₹13.6B₹12.4B₹11.0B
Revenue growth—+9%+9%+13%—
Gross profit₹5.28B₹4.06B₹3.50B₹3.13B₹2.46B
EBITDA₹2.80B₹2.71B₹2.47B₹1.96B₹1.52B
Net income₹1.92B₹1.84B₹1.61B₹1.24B₹862M
Free cash flown/a₹1.30B₹1.35B₹1.42B₹1.08B
Capital expendituren/a₹596M₹363M₹694M₹446M
Total debt₹346M₹369M₹328M₹340M₹24.8M

Quarterly statements and history in the cockpit →

Indraprastha Medical competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%+40%301103VMD2609QC73012391515VOX6062GHCARTEMISMEDKOVAIHCGGDSJLHLRHKPARKHOSPSINDRAMEDCO.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Indraprastha Medical is the large dot.

Fundamentals: revenue growth against valuation

0%+5%+10%+15%+20%0×25×50×75×VMDQC73012391515VOX6062GHCARTEMISMEDHCGCBAVJLHLPARKHOSPSINDRAMEDCO.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Indraprastha Medical is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%KMCSHIL301103VMD2609QC73012391515VOXGHCARTEMISMEDKOVAIA50GDSCBAVPARKHOSPSINDRAMEDCO.NSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Indraprastha Medical is the large dot.

Indraprastha Medical competitors and peer comparison

How Indraprastha Medical compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Indraprastha Medical against its 20 peers (data as of 18 Nov 2026)
MeasureINDRAMEDCO.NSPeer medianRank in peer set
1-month return+13.5%-2.1%5th highest of 20
6-month return-0.4%-5.6%8th highest of 19
Distance from 52-week high-35.4%-18.4%2nd lowest of 21
Revenue growth (TTM)+10.7%+11.9%9th lowest of 21
Operating margin15.0%10.2%7th highest of 21
Forward P/E15.9×22.5×4th cheapest of 14
Growth the price implies (Req g, 7 yrs)14.9%6.5%6th most demanding of 17
Growth delivered (Del g)+19.3%+15.5%5th highest of 17
Hurdle (Req g minus delivered)-4.4 pp-7.1 pp8th most demanding of 17
ROIC minus cost of capital+19.5 pp+0.6 pp2nd highest of 21
EV / EBITDA10.6×14.6×8th cheapest of 18
Net debt / EBITDA-1.1×0.6×least indebted of 18

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Indraprastha Medical INDRAMEDCO.NSIndia$351M0%+11%15%15.9×14.9%+19.3%
KMC Speciality Hospitals (India) KMCSHIL.NSIndia$346Mn/a+35%23%n/a19.0%+24.4%
Liaoning He Eye Hospital 301103.SZChina$342M-20%+3%4%n/a-4.2%+5.4%
Viemed Healthcare VMDUnited States$333M-9%+22%8%17.4×6.8%+15.5%
Bayzed Health 2609.HKHong Kong$375M-58%-2%5%n/a14.7%+9.2%
Q & M Dental Group (Singapore) QC7.SISingapore$326M-26%+16%9%31.6×7.7%+7.5%
Bright Eye Hospital 301239.SZChina$377M-26%+11%9%41.5×-5.1%+15.5%
China Resources Medical 1515.HKHong Kong$393M-10%0%6%5.4×-7.5%+26.3%
Voxel VOX.WAPoland$393M+59%+14%24%13.6×1.2%+12.2%
Charm Care 6062.TJapan$402M+57%+6%11%15.3×-0.4%+16.4%
Garofalo Health Care GHC.MIItaly$508M-3%+4%10%20.5×1.7%+18.3%
Artemis Medicare Services ARTEMISMED.NSIndia$582M+25%+15%13%42.3×48.5%+21.5%
Kovai Medical Center & Hospital KOVAI.NSIndia$759M+22%+17%21%n/a17.4%+18.1%
Thomson Medical A50.SISingapore$923M-18%+6%10%n/a21.2%+11.8%
HealthCare Global Enterprises HCG.NSIndia$955M-7%+13%8%88.8×n/an/a
Paras Healthcare PARASHLTH.NSIndia$962Mn/a+24%11%n/an/an/a
Ramsay Generale de Sante GDS.PAFrance$969M-25%+3%4%n/a6.1%+6.0%
Clinica Baviera CBAV.MCSpain$1.01B+2%+11%20%20.1×2.3%+19.7%
Jupiter Life Line Hospitals JLHL.NSIndia$1.01B+9%+17%16%48.8×n/an/a
Rhon-klinikum RHK.DEGermany$1.06B+15%+4%-51%22.5×n/an/a
Park Medi World PARKHOSPS.NSIndia$1.10B-4%+21%21%30.6×22.1%+10.2%

Questions

Which companies are Indraprastha Medical's closest peers?
The cockpit's peer set: KMC Speciality Hospitals (India) (KMCSHIL.NS), Liaoning He Eye Hospital (301103.SZ), Viemed Healthcare (VMD), Bayzed Health (2609.HK), Q & M Dental Group (Singapore) (QC7.SI), Bright Eye Hospital (301239.SZ), China Resources Medical (1515.HK), Voxel (VOX.WA).
Is Indraprastha Medical expensive compared with its peers?
On forward p/e it trades at 15.9× against a peer median of 22.5×, 4th cheapest of 14 in its peer set. For today's price to make sense, revenue must grow about 15% a year for seven years (Req g). Recent delivered growth is +19%, so the hurdle is -4 pp: the price already allows for a slowdown.
How has Indraprastha Medical stock performed?
Over six months to 18 Nov 2026 the shares returned -0.4% against -5.6% for the median peer; over one year -34.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.